Provide Trip Sitting & Guiding Services in Every Major City
This list is not meant to be exhaustive. We provide our trip sitting and guiding services in all major cities in Wisconsin, including those which are not listed below. If we can physically get ourselves to you, we will sit for you. If you are curious whether we are able to service your area specifically, please contact us.
- Milwaukee
- Madison
- Green Bay
- Kenosha
- Racine
- Appleton
- Waukesha
- Eau Claire
- Oshkosh
- Janesville
- West Allis
- La Crosse
- Sheboygan
- Wauwatosa
- Fond du Lac
Substances We Sit With
The one caveat to us being able to provide trip sitting and guiding services is that we cannot provide your substance of choice for personal consumption—we are unable to help with sourcing.
Please understand that psychedelics are still federally controlled substances and you assume all the risk associated with possessing and consuming these medicines.
We are here to facilitate intentional psychedelic experiences where you feel supported along the entire journey—from preparation to sacred ceremonial experience to integration. We facilitate your inner healing by holding a safe, comfortable, non-judgmental space.
- Psilocybin
- Ayahuasca
- Mescaline
- Ketamine
- MDMA/MDA
- Cannabis
- DMT
- LSD
**Psychedelic Passage does not provide psychoactive or controlled substances nor are we licensed therapists, counselors, or medical professionals. We are a harm reduction company offering trip sitting & integration coaching services.**
Psychedelic Reform in Wisconsin
We are in the midst of a psychedelic renaissance and the legal status of psychedelic substances is evolving rapidly. Though there aren’t any legislative updates for Wisconsin, the state is home to groundbreaking research and education in the psychedelic field.
Usona Institute, a nonprofit medical research organization will have it’s headquarters in Fitchburg, Wisconsin opening in 2024. The organization has led several psychedelic-focused clinical trials of various substances, most notably receiving FDA Breakthrough Therapy designation for its study of psilocybin’s effect on patients with Major Depressive Disorder.
In the field of education, the University of Wisconsin-Madison is now offering a Master’s of Science in Psychoactive Pharmaceutical Investigation, a pharmacy master’s program on psychedelics. The program will include topics regarding the science, history, legality, and ethics surrounding psychedelic substances.
UW-Madison was already one of the designated sites for Usona Institute’s phase 2 study of psilocybin, so it is promising to see the higher learning institution adopting psychedelic-related study in other disciplines and degrees. We will continue to update this section as new developments arise.
